Health Care · Pharmaceutical Preparations · OTC · CIK 1807983 · FYE Mar 31 · Prices AT CLOSE 2026-07-29 (USD) — end-of-day, never a live or intraday quote
Last $0.24Day −3.20%Mkt cap $17M1Y −61.0%Off 52W high −82.7%Vol (1Y) 81.3%
Daily closing price, split-adjusted to the current basis; 2.7y shown of 1,833 bars on file. Sampled to 240 points — every point is a real close, none averaged. Price return, not total return (dividends excluded). Source marketstack.
| Short interest0.8% of sh out |
| Days to cover3.0d |
Short interest is FINRA semi-monthly, settlement 2026-07-15.
| Earnings (TTM)-CAD 10.0M |
Screener basis: ratios from the latest reported fiscal year; Sales/Earnings are trailing twelve months in the reporting currency (CAD). The P/E is a trailing FULL-YEAR P/E, not TTM. Missing lines are absent from the filings, never imputed.
| YTD−64.2% |
| 1Y−61.0% |
| 3Y+36.7% |
| 5Y−64.9% |
| 10Y−97.3% |
| Since incept. (ann.)−30.2% |
Total return through 2026-07-29 · series begins 2016-07-11. Only the windows this history actually covers are shown.
| Ann. volatility (1Y)81.3% |
| Ann. volatility (3Y)97.6% |
| Sharpe (1Y)−0.76 |
| Sharpe (3Y)0.57 |
| Max drawdown (1Y)−79.8% |
| Max drawdown (3Y)−88.4% |
| Beta (3Y vs SPY)1.60 |
Daily simple returns, annualized; drawdown is peak-to-trough within the window. Beta is the OLS slope of monthly returns on SPY's over three years. Each figure is labeled by the window it was measured over — they are not comparable across windows.
No 13F holders on file for MDNAF.
No reported quarters on file for MDNAF.
